BOOSTING ONCOLOGY RESEARCH WITH BUILT-IN KRAS ASSAY PRODUCTS AND SERVICES AND RAS ASSAYS

during the promptly evolving discipline of oncology analysis, correct and economical mutation screening is crucial for building qualified therapies. The KRAS providers System plays a pivotal job During this landscape by featuring detailed methods for KRAS mutation profiling and analysis. KRAS mutations, present in close to 95% of RAS-relevant oncog